Your browser doesn't support javascript.
loading
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Follmann, Dean; Janes, Holly E; Chu, Eric; Jayashankar, Lakshmi; Petropoulos, Christos J; Serebryannyy, Leonid; Carroll, Robin; Jean-Baptiste, Naz; Narpala, Sandeep; Lin, Bob C; McDermott, Adrian; Novak, Richard M; Graciaa, Daniel S; Rolsma, Stephanie; Magaret, Craig A; Doria-Rose, Nicole; Corey, Lawrence; Neuzil, Kathleen M; Pajon, Rolando; Miller, Jacqueline M; Donis, Ruben O; Koup, Richard A; Baden, Lindsey R; El Sahly, Hana M.
Afiliación
  • Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Chu E; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Petropoulos CJ; LabCorp-Monogram Biosciences, South San Francisco, California, USA.
  • Serebryannyy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Carroll R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Jean-Baptiste N; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • McDermott A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Novak RM; Section of Infectious Diseases, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Graciaa DS; Hope Clinic, Emory Vaccine Center, Division of Infectious Diseases, Emory University School of Medicine, Decatur, Georgia, USA.
  • Rolsma S; Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
  • Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Doria-Rose N; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Neuzil KM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Pajon R; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Miller JM; Moderna, Inc., Cambridge, Massachusetts, USA.
  • Donis RO; Moderna, Inc., Cambridge, Massachusetts, USA.
  • Koup RA; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Baden LR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • El Sahly HM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Open Forum Infect Dis ; 10(3): ofad069, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36895286
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos